Related references
Note: Only part of the references are listed.Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy
Nicholas A. Marston et al.
EUROPEAN HEART JOURNAL (2021)
A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy
Anastasia Miron et al.
CIRCULATION (2020)
A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy
Gabrielle Norrish et al.
EUROPACE (2019)
Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
Myriam Lafreniere-Roula et al.
EUROPEAN HEART JOURNAL (2019)
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)
Gabrielle Norrish et al.
JAMA CARDIOLOGY (2019)
Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom
Gabrielle Norrish et al.
EUROPEAN HEART JOURNAL (2019)
Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy
Anna Axelsson Raja et al.
CIRCULATION (2018)
Long-Term Outcomes of Hypertrophic Cardiomyopathy Diagnosed During Childhood: Results From a National Population-Based Study
Peta M. A. Alexander et al.
CIRCULATION (2018)
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events
Niccolo Maurizi et al.
JAMA CARDIOLOGY (2018)
Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis
Gabrielle Norrish et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts
Pier D. Lambiase et al.
HEART RHYTHM (2016)
Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial
Anna Axelsson et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
Raymond H. Chan et al.
CIRCULATION (2014)
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
Constantinos O'Mahony et al.
EUROPEAN HEART JOURNAL (2014)
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M. Elliott et al.
EUROPEAN HEART JOURNAL (2014)
Cardiovascular Magnetic Resonance Characteristics in Children With Hypertrophic Cardiomyopathy
Yan Chaowu et al.
CIRCULATION-HEART FAILURE (2013)
Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy
Barry J. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Progression of Myocardial Fibrosis Assessed With Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy
Giancarlo Todiere et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Prognostic Value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic Cardiomyopathy
John J. Green et al.
JACC-CARDIOVASCULAR IMAGING (2012)
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Bernard J. Gersh et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2011)
Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
Giovanni Donato Aquaro et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2010)
Risk Factors and Mode of Death in Isolated Hypertrophic Cardiomyopathy in Children
Jamie A. Decker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance
Martin S. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Implantable Cardioverter Defibrillator Criteria for Primary and Secondary Prevention of Pediatric Sudden Cardiac Death
Charles I. Berul
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2009)
Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children - Findings from the Pediatric Cardiomyopathy Registry
Steven D. Colan et al.
CIRCULATION (2007)
Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy
Kevin M. Harris et al.
CIRCULATION (2006)
Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance
A. M. Maceira et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2006)
Clinical features and outcomes of childhood hypertrophic cardiomyopathy - Results from a national population-based study
AW Nugent et al.
CIRCULATION (2005)
Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy
C Rickers et al.
CIRCULATION (2005)
The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy
JCC Moon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy
MS Maron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Hypertrophic cardiomyopathy - A systematic review
BJ Maron
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
